CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$56.80 USD
+2.04 (3.73%)
Updated May 22, 2024 04:00 PM ET
After-Market: $56.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.39 | 5.14% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.43 per share, beating the Zacks Consensus Estimate of $-1.63 per share. This reflects a positive earnings surprise of 12.27%. Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.39 per share, reflecting a year-over-year decrease of 41.84%.
Earnings History
Price & Consensus
Zacks News for CRSP
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services